468
Views
55
CrossRef citations to date
0
Altmetric
Research Article

Spectroscopic, calorimetric and molecular docking insight into the interaction of Alzheimer’s drug donepezil with human transferrin: implications of Alzheimer’s drug

, , , ORCID Icon, &
Pages 1094-1102 | Received 19 Feb 2019, Accepted 11 Mar 2019, Published online: 02 Apr 2019

References

  • Abdulilah, E. (2019). Towards more effective acetylcholinesterase inhibitors: A comprehensive modelling study based on human acetylcholinesterase protein-drug complex. Journal of Biomolecular Structure and Dynamics, 1. doi: 10.1080/07391102.2019.1583606
  • Ajmal, M. R., Abdelhameed, A. S., Alam, P., & Khan, R. H. (2016). Interaction of new kinase inhibitors cabozantinib and tofacitinib with human serum alpha-1 acid glycoprotein. A comprehensive spectroscopic and molecular Docking approach. Spectrochimica Acta. Part A, Molecular and Biomolecular Spectroscopy, 159, 199–208. doi: 10.1016/j.saa.2016.01.049
  • Alam, P., Chaturvedi, S. K., Siddiqi, M. K., Rajpoot, R. K., Ajmal, M. R., Zaman, M., & Khan, R. H. (2016). Vitamin k3 inhibits protein aggregation: Implication in the treatment of amyloid diseases. Scientific Reports, 6, 26759. doi: 10.1038/srep26759
  • Aliev, G., Ashraf, G. M., Tarasov, V. V., Chubarev, V. N., Leszek, J., Gasiorowski, K., … Bachurin, S. O. (2018). Alzheimer disease-future therapy based on dendrimers. Current Neuropharmacology, 17(3), 288–294.
  • Bannister, W. H., & Bannister, J. V. (1974). Circular dichroism and protein structure. International Journal of Biochemistry, 5(9/10), 673–677. doi: 10.1016/0020-711X(74)90052-4
  • Berman, H. M., Westbrook, J., Feng, Z., Gilliland, G., Bhat, T. N., Weissig, H., Shindyalov, I. N., & Bourne, P. E. (2000). The protein data bank nucleic acids research. Nucleic Acids Research, 28(1), 235–242.
  • Birks, J. S. (2006). Cholinesterase inhibitors for Alzheimer's disease. Cochrane Database of Systematic Reviews, 1.
  • DeLano, W. L. (2002). The PyMOL user’s manual. San Carlos, CA: DeLano Scientific, 452.
  • Barr AJ. (2018). The biochemical basis of disease. Essays in Biochemistry, 62 (5):619–642. doi: 10.1042/EBC20170054
  • Geldmacher, D. S. (2004). Donepezil (Aricept) for treatment of Alzheimer's disease and other dementing conditions. Expert Review of Neurotherapeutics, 4(1), 5–16. doi: 10.1586/14737175.4.1.5
  • Greenfield, N. J., & Fasman, G. D. (1969). Computed circular dichroism spectra for the evaluation of protein conformation. Biochemistry, 8(10), 4108–4116. doi: 10.1021/bi00838a031
  • Hurd, M. D., Martorell, P., Delavande, A., Mullen, K. J., & Langa, K. M. (2013). Monetary costs of dementia in the United States. The New England Journal of Medicine, 368(14), 1326–1334. doi: 10.1056/NEJMsa1204629
  • Inoue, A., Kawai, T., Wakita, M., Iimura, Y., Sugimoto, H., & Kawakami, Y. (1996). The simulated binding of (±)-2,3-dihydro-5,6-dimethoxy-2-[1-(phenylmethyl)-4-piperidinyl)methyl]-1H-inden-1-one hydrochloride (E2020) and related inhibitors to free and acylated acetylcholinesterases and corresponding structure-activity analysis. Journal of Medicinal Chemistry, 39(22), 4460–4470. doi: 10.1021/jm950596e
  • Ishtikhar, M., Khan, S., Badr, G., Mohamed, A. O., & Khan, R. H. (2014). Interaction of the 5-fluorouracil analog 5-fluoro-2′-deoxyuridine with ‘N’and ‘B’isoforms of human serum albumin: a spectroscopic and calorimetric study. Molecular BioSystems, 10(11), 2954–2964. doi: 10.1039/C4MB00306C
  • Jaumot, J., & Gargallo, R. (2012). Experimental methods for studying the interactions between G-quadruplex structures and ligands. Current Pharmaceutical Design, 18(14), 1900–1916. doi: 10.2174/138161212799958486
  • Klajnert, B., Stanisławska, L., Bryszewska, M., & Pałecz, B. (2003). Interactions between PAMAM dendrimers and bovine serum albumin. Biochimica et Biophysica Acta (BBA)-Proteins and Proteomics, 1648(1–2), 115–126. doi: 10.1016/S1570-9639(03)00117-1
  • Knowles, J. (2006). Donepezil in Alzheimer's disease: an evidence-based review of its impact on clinical and economic outcomes . Core Evidence, 1(3), 195–219.
  • Kumar, A., & Ekavali, A. S. (2015). A review on Alzheimer’s disease pathophysiology and its management: An update. Pharmacological Reports, 67, 195–203.
  • Mariam, J., Dongre, P. M., & Kothari, D. C. (2011). Study of interaction of silver nanoparticles with bovine serum albumin using fluorescence spectroscopy. Journal of Fluorescence, 21(6), 2193. doi: 10.1007/s10895-011-0922-3
  • McGleenon, B. M., Dynan, K. B., & Passmore, A. P. (1999). Acetylcholinesterase inhibitors in Alzheimer’s disease. British Journal of Clinical Pharmacology, 484, 471.
  • Norgan, A. P., Coffman, P. K., Kocher, J.-P. A., Katzmann, D. J., & Sosa, C. P. (2011). Multilevel parallelization of AutoDock 4.2. Journal of Cheminformatics, 3(1), 12. doi: 10.1186/1758-2946-3-12
  • Qais, F. A., Alam, M. M., Naseem, I., & Ahmad, I. (2016). Understanding the mechanism of non-enzymatic glycation inhibition by cinnamic acid: an in vitro interaction and molecular modelling study. RSC Advances, 6(70), 65322–65337. doi: 10.1039/C6RA12321J
  • Saini, R. K., Shuaib, S., Goyal, D., & Goyal, B. (2018). Insights into the inhibitory mechanism of a resveratrol and clioquinol hybrid against Aβ42 aggregation and protofibril destabilization: A molecular dynamics simulation study. Journal of Biomolecular Structure & Dynamics, 1–15. doi: 10.1080/07391102.2018.1511475
  • Rehman, M. T., Shamsi, H., & Khan, A. U. (2014). Insight in to the binding mechanism of imipenem to human serum albumin by spectroscopic and computational approaches. Molecular Pharmaceutics, 11(6), 1785–1797. doi: 10.1021/mp500116c
  • Saxena, V. P., & Wetlaufer, D. B. (1971). A new basis for interpreting the circular dichroic spectra of proteins. Proceedings of the National Academy of Sciences of the United States of America, 68(5), 969–972. doi: 10.1073/pnas.68.5.969
  • Shamsi, A., Ahmed, A., & Bano, B. (2018). Probing the interaction of anticancer drug temsirolimus with human serum albumin: molecular docking and spectroscopic insight. Journal of Biomolecular Structure and Dynamics, 36(6), 1479–1489. doi: 10.1080/07391102.2017.1326320
  • Shamsi, A., Ahmed, A., Khan, M. S., Husain, F. M., Amani, S., & Bano, B. (2018). Investigating the interaction of anticancer drug temsirolimus with human transferrin: Molecular docking and spectroscopic approach. Journal of Molecular Recognition, 31(10), e2728. doi: 10.1002/jmr.2728
  • Shigeta, M., & Homma, A. (2006). Donepezil for Alzheimer’s Disease: Pharmacodynamic, pharmacokinetic, and clinical profiles. CNS Drug Reviews, 7(4), 353–368. doi: 10.1111/j.1527-3458.2001.tb00204.x
  • Shintani, E. Y., & Uchida, K. M. (1997). Donepezil: An anticholinesterase inhibitor for Alzheimer's disease. American Journal of Health-System Pharmacy, 54(24), 2805–2810. doi: 10.1093/ajhp/54.24.2805
  • Simoes, M. C. R., Viegas, F. P. D., Moreira, M. S., de Freitas Silva, M., Riquiel, M. M., da Rosa, P. M., … Viegas, C. Jr. (2014). Donepezil: An important prototype to the design of new drug candidates for Alzheimer's disease. Mini Reviews in Medicinal Chemistry, 14(1), 2–19.
  • Sliwoski, G., Kothiwale, S., Meiler, J., & Lowe, E. W. (2013). Computational methods in drug discovery. Pharmacological Reviews, 66(1), 334–395. doi: 10.1124/pr.112.007336
  • Sugimoto, H., Iimura, Y., Yamanishi, Y., & Yamatsu, K. (1995). Synthesis and structure-activity-relationship of acetylcholinesterase inhibitors 1-Benzyl-4-[(5,6)-dimethoxy-1-oxoindan-2-yl)-methyl]piperidine hydrochloride and related compounds. Journal of Medicinal Chemistry, 38(24), 4821–4829. doi: 10.1021/jm00024a009
  • Tabassum, S., Al-Asbahy, W. M., Afzal, M., Arjmand, F., & Khan, R. H. (2012). Interaction and photo-induced cleavage studies of a copper based chemotherapeutic drug with human serum albumin: spectroscopic and molecular docking study. Molecular BioSystems, 8(9), 2424–2433. doi:10.1039/c2mb25119a
  • Thompson, K., Menzies, S., Muckenthaler, M., Torti, F. M., Wood, T., Torti, S. V., … Connor, J. (2003). Mouse brains deficient in H‐ferritin have normal iron concentration but a protein profile of iron deficiency and increased evidence of oxidative stress. Journal of Neuroscience Research, 71(1), 46–63. doi: 10.1002/jnr.10463
  • Tian, W., Chen, C., Lei, X., Zhao, J., & Liang, J. (2018). CASTp 3.0: Computed atlas of surface topography of proteins. Nucleic Acids Research, 46(W1), W363–W367.
  • Tong, J.-Q., Tian, F.-F., Li, Q., Li, L.-L., Xiang, C., Liu, Y., & Jiang, F.-L. (2012). Probing the adverse temperature dependence in the static fluorescence quenching of BSA induced by a novel anticancer hydrazone. Photochemical & Photobiological Sciences, 11(12), 1868–1879. doi: 10.1039/c2pp25162k
  • Tsopelas, N. D., & Martin, D. B. (2001). Cholinergic treatments of Alzheimer’s disease. In P. R. Hof, and C. V., Mobbs, (Eds.), Functional neurobiology of aging (pp. 475–486). New York: Academic Press. doi: 10.1016/B978-0-12-351830-9.X5000-8
  • Tsuno, N. (2009). Donepezil in the treatment of patients with Alzheimer's disease. Expert Review of Neurotherapeutics, 9(5), 591–598. doi: 10.1586/ern.09.23
  • Ultra, C. (2010). 6.0 and Chem3D Ultra version 12.0. Cambridge Soft Corporation, Cambridge, USA.
  • Watanabe, H., Tanase, S., Nakajou, K., Maruyama, T., Kragh-Hansen, U., & Otagiri, M. (2000). Role of Arg-410 and Tyr-411 in human serum albumin for ligand binding and esterase-like activity. Biochemical Journal, 349(3), 813–819. doi: 10.1042/bj3490813
  • Wilkinson, D. G. (1999). The pharmacology of donepezil: a new treatment of Alzheimer's disease. Expert Opinion on Pharmacotherapy, 1(1), 121–135. doi: 10.1517/14656566.1.1.121
  • Zaidi, N., Ajmal, M. R., Rabbani, G., Ahmad, E., & Khan, R. H. (2013). A comprehensive insight into binding of hippuric acid to human serum albumin: A study to uncover its impaired elimination through hemodialysis. PloS One, 8(8), e71422. doi: 10.1371/journal.pone.0071422

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.